OSCO 2021 “Best of” SABCS® Virtual Symposium

Join OSCO for the Official “Best of” San Antonio Breast Cancer Symposium® to be presented virtually.  This conference is designed to provide state-of-the art information on the experimental biology, etiology, prevention, diagnosis and therapy of breast cancer and premalignant breast disease.

This seminar is directed towards health care professionals involved in breast cancer in medical, surgical, gynecologic and radiation oncology.

  • Official Best of SABCS® is an initiative of Encore Medical Education.
  • This conference is jointly provided by Postgraduate Institute for Medicine and Oklahoma Society of Clinical Oncology, Inc.
  • This activity has been approved for AMA PRA Category 1 Credit(s) for physicians and education credits for other allied health professionals

Pharmaceutical Companies interested in Corporate Membership? Join here →

Companies interested in a virtual exhibit for Spring and/or Fall Conference? Purchase here →

Show Agenda
  • 7:30 AM
    Virtual Exhibitor Booths Open
  • 7:50 AM - 8:00 AM
    Welcome Remarks
    Jose Eugenio Najera, MD

    Jose Eugenio Najera, MD

    OSCO President

  • 8:00 AM - 8:15 AM
    Break with Virtual Exhibitors
  • 8:15 AM - 9:10 AM
    Topic: Update on Abstracts Relating to TNBC
    Kari Wisinski, MD

    Kari Wisinski, MD

    Associate Professor & Director of Breast Medical Oncology

    Division of Hematology/Oncology, University of Wisconsin Carbone Cancer Center

  • 9:10 AM - 9:25 AM
    Break with Virtual Exhibitors
  • 9:25 AM - 10:20 AM
    Topic: TBD
    Virginia  G. Kaklamani, MD

    Virginia G. Kaklamani, MD

    Professor, Hematology/Oncology

    UT Health San Antonio - Mays Cancer Center

  • 10:20 AM - 10:35 AM
    Break with Virtual Exhibitors
  • 10:35 AM - 11:30 AM
    Topic: Residual Cancer Burden
    William Fraser Symmans, MB. ChB.

    William Fraser Symmans, MB. ChB.

    Director of Research Operations

    Department of Pathology - University of Texas MD Anderson

  • 11:30 AM - 11:45 AM
    Break with Virtual Exhibitors
  • 11:45 AM - 12:40 PM
    Topic: First Report on RxPONDER Trial
    Steven Vogl, MD

    Steven Vogl, MD

    Medical Oncology, Former Columnist for The ASCO Post, Bronx, NY

  • 12:40 PM